Molecular mass: 543.364 g/mol PubChem compound: 119117
Indium forms a saturated (1:3) complex with oxyquinoline. The complex is neutral and lipid-soluble, which enables it to penetrate the cell membrane. It is thought likely that the mechanism of labeling cells with indium In-111 oxyquinoline involves an exchange reaction between the oxyquinoline carrier and subcellular components which chelate indium more strongly than oxyquinoline.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09HB01 | Indium (111In) oxinate labelled cells | V Various → V09 Diagnostic radiopharmaceuticals → V09H Inflammation and infection detection → V09HB Indium (111In) compounds |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| INDIUM IN-111 OXYQUINOLINE Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
